Investment highlights
Intellectual Asset
Advance patents for eye-drop therapeutic platform for retinal diseases
Peptide delivery platform → Advantageous position for expediting innovations
Market Growth
Market size and demand continues to grow rapidly due to increased average lifespans
Quick entry into addressable market
Differentiated technology & product from existing developers
Accumulative Data
Verified data accumulated through joint research and collaboration with leading research institutes
Strong research capabilities through NT R&D Center
(Managements + Researchers)
Competitive management team
Global risk management capabilities
High Probability of License Deal
Differentiated technology that will serve as a valuable addition to any portfolio
→ NT Technology
Accelerated Tech self-sufficiency
Early advancement towards tech Self-Sufficiency IPO through technological innovation and drive
PR Center